The use of artrofoon in the treatment of ankylosing spondyloarthritis.
In patients with ankylosing spondyloarthritis, artrofoon produced a more potent antiinflammatory effect than nonsteroidal antiinflammatory drugs. The study demonstrated a positive effect of artrofoon on clinical and laboratory parameters, good tolerability of the preparation, and the absence of negative effects on the hepatic and renal functions. Being added to complex therapy, artrofoon led to a decrease in the dose of nonsteroidal antiinflammatory drugs.
Kudryavtseva
I V
IV
Consultative-Diagnostic Polyclinics No. 14, Novosibirsk.
Ukolova
L A
LA
Chizhov
N N
NN
Braginskaya
N M
NM
Istranen
I A
IA
Kozhevnikov
O P
OP
D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000276:immunology / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D013167:Spondylitis, Ankylosing / Q000188:drug therapy*; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology
D000911:Antibodies, Monoclonal; C503436:Artrofoon; D014409:Tumor Necrosis Factor-alpha